Archived Newsletters

21. 06.03.25 -- Is Early Automation The Key To Scalable Cell Therapy Manufacturing? 6/3/2025
    06/03/25 Outsourced Pharma Newsletter
22. 06.02.25 -- STREAM Edition: Challenges In ADC Process Development 6/2/2025

    06/02/25 Outsourced Pharma Newsletter

23. 06.02.25 -- STREAM Edition: Evolve Or Fade Away? Biotech's Outsourcing Moment In Trump's Tariff Tangle 6/2/2025

    06/02/25 Outsourced Pharma Newsletter

24. 05.30.25 -- Partnering For Efficient And Reliable Fill/Finish Operations 5/30/2025
    05/30/25 Outsourced Pharma Newsletter
25. 05.30.25 -- To Enhance Biotech Investments, Involve CDMOs Early In CMC Decisions 5/30/2025
    05/30/25 Outsourced Pharma Newsletter
26. 05.29.25 -- Enhance Safety In Cell And Gene Therapies 5/29/2025

    05/29/25 Outsourced Pharma Newsletter

27. 05.29.25 -- Take Your Small Molecule Drug Development To The Next Level 5/29/2025
    05/29/25 Outsourced Pharma Newsletter
28. 05.29.25 -- Squeezing CDMOs Dry? One Big Pharma VP Says Enough Is Enough 5/29/2025
    05/29/25 Outsourced Pharma Newsletter
29. 05.28.25 -- Discover Partners Focused On Cell & Gene Therapy 5/28/2025
    05/28/25 Outsourced Pharma Newsletter
30. 05.28.25 -- Bridging Modalities: CDMO Innovation In CGT And Small Molecule Development 5/28/2025

    05/28/25 Outsourced Pharma Newsletter